| Patent Number | Title | Applicant | Opposition Date |
|---|---|---|---|
| EP3033086 | Combination Therapy For The Treatment Of Cancer | NOVARTIS AG | Jun 22, 2022 |
| EP3135275 | Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline Modifications | GRINDEKS, A JOINT STOCK COMPANY | Feb 11, 2021 |
| EP3042659 | Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione | CELGENE CORPORATION | Aug 7, 2019 |
Feel free to send us a message here and we will get back to you